Inventor
KIRKLAND THOMAS
US53 patents
⚠️ This page may combine multiple inventors who share the name “KIRKLAND THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROMEGA CORP
45 patentsUS9797890B2Oct 24, 2017
Activation of bioluminescence by structural complementation
PROMEGA CORP24 citations97
US9797889B2Oct 24, 2017
Activation of bioluminescence by structural complementation
PROMEGA CORP33 citations97
US10288605B2May 14, 2019
Activation of bioluminescence by structural complementation
PROMEGA CORP10 citations92
US10107800B2Oct 23, 2018
Activation of bioluminescence by structural complementation
PROMEGA CORP14 citations92
US9869670B2Jan 16, 2018
Activation of bioluminescence by structural complementation
PROMEGA CORP12 citations92
US11493504B2Nov 8, 2022
Activation of bioluminescene by structural complementation
PROMEGA CORP4 citations83
US10648971B2May 12, 2020
Activation of bioluminescence by structural complementation
PROMEGA CORP6 citations83
US10618907B2Apr 14, 2020
Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements
PROMEGA CORP5 citations83
US10308975B2Jun 4, 2019
Substituted imidazo[1,2-a]pyrazines as luciferase substrates
PROMEGA CORP4 citations83
US10184936B2Jan 22, 2019
Activation of bioluminescence by structural complementation
PROMEGA CORP5 citations83
US10000500B2Jun 19, 2018
Coelenterazine analogues
PROMEGA CORP6 citations83
US9924073B2Mar 20, 2018
Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereof
PROMEGA CORP5 citations83
US9551705B2Jan 24, 2017
Compositions and methods for capture of cellular targets of bioactive agents
PROMEGA CORP6 citations83
US10067149B2Sep 4, 2018
Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
PROMEGA CORP14 citations82
US10024862B2Jul 17, 2018
Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
PROMEGA CORP13 citations82
US10280447B2May 7, 2019
Substituted imidazo[1,2-A]pyrazines tethered to energy acceptors
PROMEGA CORP4 citations73
US9676997B2Jun 13, 2017
Compositions and methods for stabilizing luminogenic substrates
PROMEGA CORP3 citations73
US11072812B2Jul 27, 2021
Substrates for covalent tethering of proteins to functional groups or solid surfaces
PROMEGA CORP3 citations72
US10571471B2Feb 25, 2020
Luciferase-based thermal shift assays
PROMEGA CORP2 citations72
US10428075B2Oct 1, 2019
Coelenterazine analogues
PROMEGA CORP4 citations72
US10168323B2Jan 1, 2019
Compositions and methods for capture of cellular targets of bioactive agents
PROMEGA CORP5 citations72
US12391973B2Aug 19, 2025
Substituted imidazo[1,2-α]pyrazines as luciferase substrates
PROMEGA CORP0 citations62
US12367513B2Jul 22, 2025
Activation of bioluminescence by structural complementation
PROMEGA CORP0 citations62
US12366572B2Jul 22, 2025
Activation of bioluminescence by structural complementation
PROMEGA CORP0 citations62
US11899021B2Feb 13, 2024
Luciferase-based thermal shift assays
PROMEGA CORP0 citations62
US11781168B2Oct 10, 2023
Process for preparing substituted imidazo[1,2-α]pyrazines
PROMEGA CORP0 citations62
US11567083B2Jan 31, 2023
Luciferase-based thermal shift assays
PROMEGA CORP0 citations62
US11534504B2Dec 27, 2022
Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof
PROMEGA CORP0 citations62
US11261478B2Mar 1, 2022
Thermal stable luciferase with improved resistance to inhibition by luciferin break-down products
PROMEGA CORP0 citations62
US11192894B2Dec 7, 2021
Cell impermeable coelenterazine analogues
PROMEGA CORP0 citations62
US11072811B2Jul 27, 2021
Substrates for covalent tethering of proteins to functional groups or solid surfaces
PROMEGA CORP0 citations62
US11015216B2May 25, 2021
Substituted imidazo[1,2-a]pyrazines as luciferase substrates
PROMEGA CORP0 citations62
US10928400B2Feb 23, 2021
Luciferase-based thermal shift assays
PROMEGA CORP0 citations62
US10577370B2Mar 3, 2020
Cell impermeable coelenterazine analogues
PROMEGA CORP1 citations62
US12545899B2Feb 10, 2026
Luciferase enzymes for use with thermostable luciferins in bioluminescent assays
PROMEGA CORP0 citations61
US12221648B2Feb 11, 2025
Substrates for covalent tethering of proteins to functional groups or solid surfaces
PROMEGA CORP0 citations61
US11767517B2Sep 26, 2023
Luciferase enzymes for use with thermostable luciferins in bioluminescent assays
PROMEGA CORP0 citations61
US11740249B2Aug 29, 2023
Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
PROMEGA CORP1 citations61
US11667648B2Jun 6, 2023
Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements
PROMEGA CORP0 citations61
US10976312B2Apr 13, 2021
Compositions and methods for capture of cellular targets of bioactive agents
PROMEGA CORP0 citations61
US10882035B2Jan 5, 2021
Palladium catalysts with improved performance in biological environments
PROMEGA CORP0 citations61
US12571031B2Mar 10, 2026
Nucleic acid modifying reagents and uses thereof
PROMEGA CORP0 citations57
US10669280B2Jun 2, 2020
Coelenterazine analogues
PROMEGA CORP0 citations51
US10669568B2Jun 2, 2020
Substituted imidazo[1,2-a]pyrazines as luciferase substrates
PROMEGA CORP0 citations51
US11913944B2Feb 27, 2024
Photoaffinity probes
PROMEGA CORP0 citations50
CELLTAXIS LLC
2 patentsESTRELLITA PHARMACEUTICALS LLC
1 patentCELTAXSYS INC
1 patentARNAIZ DAMIAN O
1 patentShowing the top 50 of 53 patents by PatentIndex Score.